Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Magill

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The American Journal of Tropical Medicine and Hygiene|March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in PeruVivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.
Journal of Clinical Microbiology|June 7, 2003
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigenJ Russ Forney, Chansuda Wongsrichanalai, Alan J Magill, et al.
Vaccine|April 20, 2007
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of ResearchMark E Polhemus, Alan J Magill, James F Cummings, et al.
The New England Journal of Medicine|February 8, 2013
Topical paromomycin with or without gentamicin for cutaneous leishmaniasisAfif Ben Salah, Nathalie Ben Messaoud, Evelyn Guedri, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The American Journal of Tropical Medicine and Hygiene|March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in PeruVivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.
Journal of Clinical Microbiology|June 7, 2003
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigenJ Russ Forney, Chansuda Wongsrichanalai, Alan J Magill, et al.
Vaccine|April 20, 2007
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of ResearchMark E Polhemus, Alan J Magill, James F Cummings, et al.
The New England Journal of Medicine|February 8, 2013
Topical paromomycin with or without gentamicin for cutaneous leishmaniasisAfif Ben Salah, Nathalie Ben Messaoud, Evelyn Guedri, et al.
Pageof 5